Multicenter Analysis of Clinicopathologic Features of Intraductal Papillary Mucinous Tumor of the Pancreas: Is It Possible to Predict the Malignancy Before Surgery?
- 4 February 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 12 (2), 124-132
- https://doi.org/10.1245/aso.2005.02.030
Abstract
Despite recently increasing numbers of reports on intraductal papillary mucinous tumors (IPMTs), difficulties still remain in terms of diagnosis, treatment, and prognosis. The purpose of this multicenter study was to evaluate the clinicopathologic features of IPMT in Korea and to suggest predictive criteria for malignancy in IPMT. We retrospectively reviewed the clinicopathologic data of 208 patients who underwent operations for IPMT between 1993 and 2002 at 28 institutes in Korea. Of the 208 patients (mean age, 61 years), 147 were men and 61 were women. A total of 124 patients underwent pancreatoduodenectomy, 42 underwent distal pancreatectomy, 17 underwent total pancreatectomy, and 25 underwent limited pancreatic resection. There were 128 benign cases (adenoma, n = 62; borderline, n = 66) and 80 malignant cases (noninvasive, n = 29; invasive, n = 51). A significant difference in 5-year survival was observed between the benign and malignant groups (92.6% vs. 65.3%; P = .006). Of the six factors (age, location, duct dilatation, mural nodule, main duct type, and tumor size) that showed statistical differences by univariate analysis between the benign and malignant groups, three were significant by multivariate analysis—namely, mural nodule (P = .009), tumor size (P = .023), and a dilated duct size (P = .010). A significant proportion of IPMTs are malignant, although the overall prognosis of IPMT is superior to that of ordinary pancreatic cancer. Radical surgery is recommended for IPMT with the predictors of malignancy: mural nodule, tumor size (⩾30 mm), and dilated duct size (⩾12 mm).Keywords
This publication has 25 references indexed in Scilit:
- Predictive factors for malignancy in intraductal papillary–mucinous tumours of the pancreasBritish Journal of Surgery, 2003
- Intraductal Papillary-Mucinous Tumors of the PancreasArchives of Surgery, 2002
- Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinomaGut, 2002
- The incidence of intraductal papillary mucinous tumors of the pancreasCurrent Surgery, 2000
- Outcome After Surgical Resection of Intraductal Papillary and Mucinous Tumors of The PancreasAmerican Journal Of Gastroenterology, 2000
- Detection of K-ras and p53 Gene Mutations in Pancreatic Juice for the Diagnosis of Intraductal Papillary Mucinous TumorsPancreas, 1999
- Intraductal Papillary Mucinous Tumors of the PancreasAnnals of Surgery, 1998
- Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreasCancer, 1997
- Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients.Gut, 1996
- Intraductal Papillary Mucinous Neoplasms of the Pancreas Associated with So-called “Mucinous Ductal Ectasia” Histochemical and Immunohistochemical Analysis of 29 CasesThe American Journal of Surgical Pathology, 1995